Member Login

Please login to the WANADA website using the below form. If you have any issues logging in please email [email protected] or contact us on (08) 6557 9400.

Request Access

If you're a WANADA member and need access to the Hub, you can request access direct from WANADA.

Forgot your password?

Accessibility Options

WANADA is committed to access and inclusion. We are always working to improve the quality and accessibility of our website.

WANADA’s website is designed to be accessible for people with disability. We strive to meet the World Wide Web Consortium’s Web Content Accessibility Guidelines (WCAG) 2.0 at level AA.

If you have any difficulties using this site please contact us via [email protected] or via (08) 6557 9400

Accessibility options that may help you to access the site include:

Text size
Contrast
Accessibility Enquiries

E [email protected]

P (08) 6557 9400

Contact Us

General Enquiries

E [email protected]

P (08) 6557 9400

Address

WANADA
Whadjuk Noongar Country
Level 1, 1 Nash St
Perth WA 6000

Postal Address

WANADA
PO Box 8048
Perth, WA 6849

Social Media

Hepatitis C Treatment Project

WANADA's Hepatitis C Treatment Project

WANADA is working with Peer Based Harm Reduction WA and alcohol and other drug services throughout the state to increase access to testing and treatment for hepatitis C, thanks to the Western Australian Department of Health

WANADA’s hepatitis C virus (HCV) project was funded for the initial phase by The Paul Ramsay Foundation, as part of the Eliminate Hepatitis C Australia Partnership co-ordinated by the Burnet Institute.

WANADA is now facilitating further upskilling of alcohol and other drug workers on hepatitis C as part of the project and will continue to support the alcohol and other drug service sector to apply the HCV Capability Assessment/Review Tool (CAT).

Building on the success of work with participating organisations, WANADA is extending the project to organisations throughout Western Australia.

Highly effective treatment for hepatitis C has been available through the Pharmaceutical Benefits Scheme since 2016. However, according to the Burnet Institute, many people living with hepatitis C remain untreated, and at serious risk of liver disease, cancer, and premature death.

Specialist alcohol and other drug services are uniquely placed to engage current and past injecting drug users, access peer networks, and reduce barriers to treatment (ensuring equity of access for hard to reach populations).

WANADA believes that addressing the alcohol and other drug sector’s hepatitis C responsiveness will also allow for subsequent consideration of Hepatitis C by related sectors, such as homelessness.

WANADA’s Hepatitis C Treatment Project is overseen by  Sector Quality Manager Rochelle McIntosh , with Consultant Tabetha McCallum engaging with services.

More Information

For more information, please contact WANADA on (08) 6557 9400 or via [email protected].